CDH2 and glioblastoma: Consistent with the decreased expression of vimentin in vitro and in vivo (Figure 5D, G-I), we observed reduced expression of N-cadherin and increased expression of E-cadherin in GBM+MSCMel tumorspheres, compared to those in the GBM+MSC or GBM group, respectively (Figure 5K-L).